Prelude Therapeutics Incorporated
PRLD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$127 | -$122 | -$115 | -$112 |
| Dep. & Amort. | $2 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $21 | $26 | $25 | $21 |
| Change in WC | $4 | -$10 | $1 | $4 |
| Other Non-Cash | -$3 | -$2 | $4 | $3 |
| Operating Cash Flow | -$103 | -$107 | -$84 | -$84 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$4 | -$3 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$53 | -$222 | -$119 | -$261 |
| Inv. Sales/Matur. | $144 | $191 | $204 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $90 | -$35 | $82 | -$264 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $0 | $0 | $0 |
| Stock Issued | $0 | $136 | $0 | $161 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $1 | $1 | $3 |
| Financing Cash Flow | -$0 | $136 | $1 | $165 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$13 | -$5 | -$1 | -$182 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29 | $35 | $36 | $218 |
| End Cash | $17 | $29 | $35 | $36 |
| Free Cash Flow | -$104 | -$111 | -$87 | -$86 |